User profiles for "author:Sean Zheng"

Sean Zheng

Imperial College London
Verified email at nhs.net
Cited by 1501

Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis

SL Zheng, AJ Roddick - Jama, 2019 - jamanetwork.com
Importance The role for aspirin in cardiovascular primary prevention remains controversial,
with potential benefits limited by an increased bleeding risk. Objective To assess the …

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality …

SL Zheng, AJ Roddick, R Aghar-Jaffar, MJ Shun-Shin… - Jama, 2018 - jamanetwork.com
Importance The comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2)
inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) …

Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis

SL Zheng, FT Chan, AA Nabeebaccus, AM Shah… - Heart, 2018 - heart.bmj.com
Background Clinical drug trials in patients with heart failure and preserved ejection fraction
have failed to demonstrate improvements in mortality. Methods We systematically searched …

Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 …

MJ Shun-Shin, SL Zheng, GD Cole… - European heart …, 2017 - academic.oup.com
Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy

A de Marvao, KA McGurk, SL Zheng, M Thanaj… - Journal of the American …, 2021 - jacc.org
Background Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-
encoding genes, but little is known about the clinical significance of these variants in the …

[HTML][HTML] Correspondence on “ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American …

KA McGurk, SL Zheng, A Henry, K Josephs… - Genetics in …, 2022 - gimjournal.org
We were interested to read the recent update on recommendations for reporting of
secondary findings in clinical sequencing 1 and the accompanying updated list of genes in …

Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate

A Gupta, SL Zheng - Archives of Disease in Childhood, 2017 - adc.bmj.com
Genetic mutations affecting proteins required for normal surfactant protein function are a rare
cause of respiratory disease. The genes identified that cause respiratory disease are …

Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy

L Curran, A de Marvao, P Inglese… - Circulation: Genomic …, 2023 - Am Heart Assoc
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an important cause of sudden
cardiac death associated with heterogeneous phenotypes, but there is no systematic …

[HTML][HTML] Heart failure—potential new targets for therapy

A Nabeebaccus, S Zheng, AM Shah - British medical bulletin, 2016 - ncbi.nlm.nih.gov
Introduction/background: Heart failure is a major cause of cardiovascular morbidity and
mortality. This review covers current heart failure treatment guidelines, emerging therapies …

Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease

RE Jones, DJ Hammersley, S Zheng… - European Journal of …, 2024 - Wiley Online Library
Aims To examine the relevance of genetic and cardiovascular magnetic resonance (CMR)
features of dilated cardiomyopathy (DCM) in individuals with coronary artery disease (CAD) …